GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (BSP:T1EV34) » Definitions » Purchase Of Property, Plant, Equipment

Teva Pharmaceutical Industries (BSP:T1EV34) Purchase Of Property, Plant, Equipment : R$-2,621 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Teva Pharmaceutical Industries Purchase Of Property, Plant, Equipment?

Teva Pharmaceutical Industries's purchase of property, plant, equipment for the three months ended in Dec. 2023 was R$-583 Mil. It means Teva Pharmaceutical Industries spent R$583 Mil on purchasing property, plant, equipment. Teva Pharmaceutical Industries's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Dec. 2023 was R$-2,621Mil.

Compared with last quarter (R$-736 Mil in Sep. 2023 ), Teva Pharmaceutical Industries spent less money on purchasing property, plant, equipment in Dec. 2023 (R$-583 Mil).


Teva Pharmaceutical Industries Purchase Of Property, Plant, Equipment Historical Data

The historical data trend for Teva Pharmaceutical Industries's Purchase Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teva Pharmaceutical Industries Purchase Of Property, Plant, Equipment Chart

Teva Pharmaceutical Industries Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Property, Plant, Equipment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,154.86 -2,973.64 -3,178.05 -2,874.48 -2,577.30

Teva Pharmaceutical Industries Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Purchase Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -744.85 -724.00 -577.59 -735.87 -583.08

Teva Pharmaceutical Industries Purchase Of Property, Plant, Equipment Calculation

The amount used to purchase PPE.

Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-2,621 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Teva Pharmaceutical Industries Purchase Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.


Teva Pharmaceutical Industries (BSP:T1EV34) Business Description

Address
124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the U.S. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a U.S.-based generic and specialty drug distributor.

Teva Pharmaceutical Industries (BSP:T1EV34) Headlines

No Headlines